HEADER HYDROLASE/HYDROLASE INHIBITOR 11-DEC-15 5FA7
TITLE CTX-M-15 IN COMPLEX WITH FPI-1523
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BETA-LACTAMASE;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: RESIDUES 26-291;
COMPND 5 EC: 3.5.2.6;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI;
SOURCE 3 ORGANISM_TAXID: 562;
SOURCE 4 GENE: BLAUOE-1, BLA, BLA CTX-M-15, BLA_1, BLA_2, BLA_3, BLACTX-M-15,
SOURCE 5 BLACTX-M15, CTX-M-15, ECONIH1_02760, ECONIH1_27135, ERS085368_04262,
SOURCE 6 ERS085370_01802, ERS085377_05268, ERS139214_01914, ERS139238_04648,
SOURCE 7 ERS139238_04652, ERS150880_04508, HUS2011_PI0012, PCTXM15_EC8_00003,
SOURCE 8 SK84_05077, SK86_03319;
SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI,A.N.ALEXANDER,
AUTHOR 2 M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN,F.MALOUIN,N.C.J.STRYNADKA,
AUTHOR 3 G.D.WRIGHT
REVDAT 4 20-NOV-24 5FA7 1 REMARK
REVDAT 3 20-NOV-19 5FA7 1 REMARK
REVDAT 2 27-APR-16 5FA7 1 JRNL
REVDAT 1 20-JAN-16 5FA7 0
JRNL AUTH A.M.KING,D.T.KING,S.FRENCH,E.BROUILLETTE,A.ASLI,
JRNL AUTH 2 J.A.ALEXANDER,M.VUCKOVIC,S.N.MAITI,T.R.PARR,E.D.BROWN,
JRNL AUTH 3 F.MALOUIN,N.C.STRYNADKA,G.D.WRIGHT
JRNL TITL STRUCTURAL AND KINETIC CHARACTERIZATION OF
JRNL TITL 2 DIAZABICYCLOOCTANES AS DUAL INHIBITORS OF BOTH
JRNL TITL 3 SERINE-BETA-LACTAMASES AND PENICILLIN-BINDING PROTEINS.
JRNL REF ACS CHEM.BIOL. V. 11 864 2016
JRNL REFN ESSN 1554-8937
JRNL PMID 26731698
JRNL DOI 10.1021/ACSCHEMBIO.5B00944
REMARK 2
REMARK 2 RESOLUTION. 1.67 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.10.0
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.40
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 3 NUMBER OF REFLECTIONS : 59810
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.177
REMARK 3 R VALUE (WORKING SET) : 0.175
REMARK 3 FREE R VALUE : 0.207
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130
REMARK 3 FREE R VALUE TEST SET COUNT : 3068
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.67
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.71
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.39
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 4402
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2102
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4184
REMARK 3 BIN R VALUE (WORKING SET) : 0.2081
REMARK 3 BIN FREE R VALUE : 0.2506
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.95
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 218
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3890
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 42
REMARK 3 SOLVENT ATOMS : 520
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 16.67
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.01
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.79670
REMARK 3 B22 (A**2) : -0.67460
REMARK 3 B33 (A**2) : 2.47130
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -1.49020
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.178
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.096
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.095
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.121
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.095
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 7976 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 14448 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1785 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 104 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 1181 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 7976 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 553 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 9204 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.12
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.97
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.75
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { A|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 16.6607 -3.4357 18.2839
REMARK 3 T TENSOR
REMARK 3 T11: -0.0703 T22: -0.0012
REMARK 3 T33: 0.0042 T12: 0.0017
REMARK 3 T13: -0.0365 T23: -0.0001
REMARK 3 L TENSOR
REMARK 3 L11: 0.2923 L22: 0.2412
REMARK 3 L33: 0.6122 L12: -0.0719
REMARK 3 L13: 0.0318 L23: 0.0178
REMARK 3 S TENSOR
REMARK 3 S11: -0.0249 S12: -0.0076 S13: -0.0060
REMARK 3 S21: 0.0043 S22: 0.0003 S23: -0.0209
REMARK 3 S31: 0.0140 S32: 0.0215 S33: 0.0246
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: { B|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 15.3338 -8.9331 -18.4739
REMARK 3 T TENSOR
REMARK 3 T11: -0.0731 T22: -0.0125
REMARK 3 T33: 0.0071 T12: 0.0083
REMARK 3 T13: -0.0406 T23: 0.0058
REMARK 3 L TENSOR
REMARK 3 L11: 0.3954 L22: 0.2389
REMARK 3 L33: 0.6243 L12: 0.0794
REMARK 3 L13: -0.0346 L23: -0.0072
REMARK 3 S TENSOR
REMARK 3 S11: 0.0002 S12: 0.0362 S13: -0.0014
REMARK 3 S21: -0.0097 S22: 0.0263 S23: -0.0056
REMARK 3 S31: -0.0349 S32: -0.0133 S33: -0.0265
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5FA7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-DEC-15.
REMARK 100 THE DEPOSITION ID IS D_1000216267.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-JUL-15
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : CLSI
REMARK 200 BEAMLINE : 08ID-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.00
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59836
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.670
REMARK 200 RESOLUTION RANGE LOW (A) : 70.100
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4
REMARK 200 DATA REDUNDANCY : 2.900
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.10
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 0.1M MES PH6.5,
REMARK 280 30% PEG5K MONOMETHYL ETHER, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.13500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LEU A 23
REMARK 465 TYR A 24
REMARK 465 ALA A 25
REMARK 465 GLN A 26
REMARK 465 GLY A 287
REMARK 465 LEU A 288
REMARK 465 LEU B 23
REMARK 465 TYR B 24
REMARK 465 ALA B 25
REMARK 465 GLN B 26
REMARK 465 THR B 27
REMARK 465 ALA B 28
REMARK 465 GLY B 287
REMARK 465 LEU B 288
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 HH TYR B 262 O HOH B 401 1.50
REMARK 500 H ASP B 253 O HOH B 402 1.51
REMARK 500 HG SER B 118 O HOH B 405 1.56
REMARK 500 OG SER B 70 OAN 5VR B 301 2.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 O ALA A 53 HE ARG B 191 2555 1.44
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG B 191 O - C - N ANGL. DEV. = 9.6 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 CYS A 69 -142.46 55.27
REMARK 500 VAL A 103 -144.39 -121.68
REMARK 500 SER A 220 -125.14 -107.69
REMARK 500 CYS B 69 -140.55 51.85
REMARK 500 VAL B 103 -142.30 -122.98
REMARK 500 SER B 220 -126.74 -106.55
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5VR A 301
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 5VR B 301 and SER B
REMARK 800 70
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5FAO RELATED DB: PDB
REMARK 900 RELATED ID: 5FAP RELATED DB: PDB
REMARK 900 RELATED ID: 5FAQ RELATED DB: PDB
REMARK 900 RELATED ID: 5FAS RELATED DB: PDB
REMARK 900 RELATED ID: 5FAT RELATED DB: PDB
DBREF 5FA7 A 23 288 UNP Q9EXV5 Q9EXV5_ECOLX 26 291
DBREF 5FA7 B 23 288 UNP Q9EXV5 Q9EXV5_ECOLX 26 291
SEQRES 1 A 266 LEU TYR ALA GLN THR ALA ASP VAL GLN GLN LYS LEU ALA
SEQRES 2 A 266 GLU LEU GLU ARG GLN SER GLY GLY ARG LEU GLY VAL ALA
SEQRES 3 A 266 LEU ILE ASN THR ALA ASP ASN SER GLN ILE LEU TYR ARG
SEQRES 4 A 266 ALA ASP GLU ARG PHE ALA MET CYS SER THR SER LYS VAL
SEQRES 5 A 266 MET ALA ALA ALA ALA VAL LEU LYS LYS SER GLU SER GLU
SEQRES 6 A 266 PRO ASN LEU LEU ASN GLN ARG VAL GLU ILE LYS LYS SER
SEQRES 7 A 266 ASP LEU VAL ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL
SEQRES 8 A 266 ASN GLY THR MET SER LEU ALA GLU LEU SER ALA ALA ALA
SEQRES 9 A 266 LEU GLN TYR SER ASP ASN VAL ALA MET ASN LYS LEU ILE
SEQRES 10 A 266 ALA HIS VAL GLY GLY PRO ALA SER VAL THR ALA PHE ALA
SEQRES 11 A 266 ARG GLN LEU GLY ASP GLU THR PHE ARG LEU ASP ARG THR
SEQRES 12 A 266 GLU PRO THR LEU ASN THR ALA ILE PRO GLY ASP PRO ARG
SEQRES 13 A 266 ASP THR THR SER PRO ARG ALA MET ALA GLN THR LEU ARG
SEQRES 14 A 266 ASN LEU THR LEU GLY LYS ALA LEU GLY ASP SER GLN ARG
SEQRES 15 A 266 ALA GLN LEU VAL THR TRP MET LYS GLY ASN THR THR GLY
SEQRES 16 A 266 ALA ALA SER ILE GLN ALA GLY LEU PRO ALA SER TRP VAL
SEQRES 17 A 266 VAL GLY ASP LYS THR GLY SER GLY GLY TYR GLY THR THR
SEQRES 18 A 266 ASN ASP ILE ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO
SEQRES 19 A 266 LEU ILE LEU VAL THR TYR PHE THR GLN PRO GLN PRO LYS
SEQRES 20 A 266 ALA GLU SER ARG ARG ASP VAL LEU ALA SER ALA ALA LYS
SEQRES 21 A 266 ILE VAL THR ASP GLY LEU
SEQRES 1 B 266 LEU TYR ALA GLN THR ALA ASP VAL GLN GLN LYS LEU ALA
SEQRES 2 B 266 GLU LEU GLU ARG GLN SER GLY GLY ARG LEU GLY VAL ALA
SEQRES 3 B 266 LEU ILE ASN THR ALA ASP ASN SER GLN ILE LEU TYR ARG
SEQRES 4 B 266 ALA ASP GLU ARG PHE ALA MET CYS SER THR SER LYS VAL
SEQRES 5 B 266 MET ALA ALA ALA ALA VAL LEU LYS LYS SER GLU SER GLU
SEQRES 6 B 266 PRO ASN LEU LEU ASN GLN ARG VAL GLU ILE LYS LYS SER
SEQRES 7 B 266 ASP LEU VAL ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL
SEQRES 8 B 266 ASN GLY THR MET SER LEU ALA GLU LEU SER ALA ALA ALA
SEQRES 9 B 266 LEU GLN TYR SER ASP ASN VAL ALA MET ASN LYS LEU ILE
SEQRES 10 B 266 ALA HIS VAL GLY GLY PRO ALA SER VAL THR ALA PHE ALA
SEQRES 11 B 266 ARG GLN LEU GLY ASP GLU THR PHE ARG LEU ASP ARG THR
SEQRES 12 B 266 GLU PRO THR LEU ASN THR ALA ILE PRO GLY ASP PRO ARG
SEQRES 13 B 266 ASP THR THR SER PRO ARG ALA MET ALA GLN THR LEU ARG
SEQRES 14 B 266 ASN LEU THR LEU GLY LYS ALA LEU GLY ASP SER GLN ARG
SEQRES 15 B 266 ALA GLN LEU VAL THR TRP MET LYS GLY ASN THR THR GLY
SEQRES 16 B 266 ALA ALA SER ILE GLN ALA GLY LEU PRO ALA SER TRP VAL
SEQRES 17 B 266 VAL GLY ASP LYS THR GLY SER GLY GLY TYR GLY THR THR
SEQRES 18 B 266 ASN ASP ILE ALA VAL ILE TRP PRO LYS ASP ARG ALA PRO
SEQRES 19 B 266 LEU ILE LEU VAL THR TYR PHE THR GLN PRO GLN PRO LYS
SEQRES 20 B 266 ALA GLU SER ARG ARG ASP VAL LEU ALA SER ALA ALA LYS
SEQRES 21 B 266 ILE VAL THR ASP GLY LEU
HET 5VR A 301 35
HET 5VR B 301 35
HETNAM 5VR [[(3~{R},6~{S})-6-(ACETAMIDOCARBAMOYL)-1-METHANOYL-
HETNAM 2 5VR PIPERIDIN-3-YL]AMINO] HYDROGEN SULFATE
FORMUL 3 5VR 2(C9 H16 N4 O7 S)
FORMUL 5 HOH *520(H2 O)
HELIX 1 AA1 THR A 27 GLY A 42 1 16
HELIX 2 AA2 CYS A 69 THR A 71 5 3
HELIX 3 AA3 SER A 72 GLU A 85 1 14
HELIX 4 AA4 ASN A 89 ASN A 92 5 4
HELIX 5 AA5 LYS A 98 LEU A 102 5 5
HELIX 6 AA6 ILE A 108 HIS A 112 5 5
HELIX 7 AA7 LEU A 119 SER A 130 1 12
HELIX 8 AA8 ASP A 131 GLY A 143 1 13
HELIX 9 AA9 GLY A 144 LEU A 155 1 12
HELIX 10 AB1 PRO A 167 THR A 171 5 5
HELIX 11 AB2 SER A 182 LEU A 195 1 14
HELIX 12 AB3 GLY A 200 GLY A 213 1 14
HELIX 13 AB4 SER A 220 LEU A 225 5 6
HELIX 14 AB5 ARG A 273 ASP A 286 1 14
HELIX 15 AB6 VAL B 30 GLY B 42 1 13
HELIX 16 AB7 CYS B 69 THR B 71 5 3
HELIX 17 AB8 SER B 72 SER B 84 1 13
HELIX 18 AB9 ASN B 89 ASN B 92 5 4
HELIX 19 AC1 LYS B 98 LEU B 102 5 5
HELIX 20 AC2 ILE B 108 HIS B 112 5 5
HELIX 21 AC3 LEU B 119 SER B 130 1 12
HELIX 22 AC4 ASP B 131 VAL B 142 1 12
HELIX 23 AC5 GLY B 144 LEU B 155 1 12
HELIX 24 AC6 PRO B 167 THR B 171 5 5
HELIX 25 AC7 SER B 182 LEU B 195 1 14
HELIX 26 AC8 GLY B 200 GLY B 213 1 14
HELIX 27 AC9 SER B 220 LEU B 225 5 6
HELIX 28 AD1 ARG B 273 ASP B 286 1 14
SHEET 1 AA1 5 GLN A 57 TYR A 60 0
SHEET 2 AA1 5 ARG A 44 ASN A 51 -1 N VAL A 47 O TYR A 60
SHEET 3 AA1 5 LEU A 257 THR A 264 -1 O TYR A 262 N GLY A 46
SHEET 4 AA1 5 THR A 242 TRP A 250 -1 N ILE A 249 O LEU A 257
SHEET 5 AA1 5 VAL A 230 GLY A 238 -1 N VAL A 230 O TRP A 250
SHEET 1 AA2 2 PHE A 66 ALA A 67 0
SHEET 2 AA2 2 THR A 180 THR A 181 -1 O THR A 181 N PHE A 66
SHEET 1 AA3 2 ARG A 94 ILE A 97 0
SHEET 2 AA3 2 GLY A 115 SER A 118 -1 O GLY A 115 N ILE A 97
SHEET 1 AA4 5 GLN B 57 TYR B 60 0
SHEET 2 AA4 5 ARG B 44 ASN B 51 -1 N VAL B 47 O TYR B 60
SHEET 3 AA4 5 LEU B 257 THR B 264 -1 O THR B 264 N ARG B 44
SHEET 4 AA4 5 THR B 242 TRP B 250 -1 N ASP B 245 O THR B 261
SHEET 5 AA4 5 VAL B 230 GLY B 238 -1 N VAL B 230 O TRP B 250
SHEET 1 AA5 2 PHE B 66 ALA B 67 0
SHEET 2 AA5 2 THR B 180 THR B 181 -1 O THR B 181 N PHE B 66
SHEET 1 AA6 2 ARG B 94 ILE B 97 0
SHEET 2 AA6 2 GLY B 115 SER B 118 -1 O MET B 117 N VAL B 95
LINK OG SER A 70 CAM 5VR A 301 1555 1555 1.29
LINK OG SER B 70 CAM 5VR B 301 1555 1555 1.28
CISPEP 1 GLU A 166 PRO A 167 0 -1.42
CISPEP 2 GLU B 166 PRO B 167 0 2.60
SITE 1 AC1 17 CYS A 69 SER A 70 ASN A 104 SER A 130
SITE 2 AC1 17 ASN A 132 PRO A 167 ASN A 170 LYS A 234
SITE 3 AC1 17 THR A 235 GLY A 236 SER A 237 HOH A 401
SITE 4 AC1 17 HOH A 539 HOH A 549 HOH A 568 HOH A 571
SITE 5 AC1 17 HOH A 579
SITE 1 AC2 21 MET B 68 CYS B 69 THR B 71 SER B 72
SITE 2 AC2 21 LYS B 73 ASN B 104 SER B 130 ASN B 132
SITE 3 AC2 21 GLU B 166 PRO B 167 ASN B 170 THR B 216
SITE 4 AC2 21 LYS B 234 THR B 235 GLY B 236 SER B 237
SITE 5 AC2 21 HOH B 441 HOH B 507 HOH B 523 HOH B 561
SITE 6 AC2 21 HOH B 572
CRYST1 62.730 60.270 76.010 90.00 112.78 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015941 0.000000 0.006695 0.00000
SCALE2 0.000000 0.016592 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014269 0.00000